Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane

被引:0
作者
Lucarelli, E
Sangiorgi, L
Benassi, S
Donati, D
Gobbi, GA
Picci, P
Vacca, A
Ribatti, D
机构
[1] Univ Bari, Sch Med, Policlin, Inst Human Anat Histol & Embryol, I-70124 Bari, Italy
[2] Univ Bari, Sch Med, Dept Biomed Sci & Human Oncol, Inst Human Anat Histol & Embryol, I-70124 Bari, Italy
[3] Rizzoli Orthoped Inst, Lab Oncol Res, I-40136 Bologna, Italy
关键词
angiogenesis; lipoma; chorioallantoic membrane;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lipoma is one of the most common benign mesenchymal tumors. Its ability to trigger an angiogenic response is a critical step for its growth. Because adipose tissue serves as an important conduit for the vasculature, it is conceivable that the angiogenic properties of this tissue may modulate the growth of the vasculature in a paracrine manner. We investigated in vivo the angiogenic potential of bioptic fragments of human lipoma by using the chick embryo chorioallantoic membrane (CAM), a useful model for such an investigation. The angiogenic response in pathological and control implants was assessed on histologic sections by a morphometric method, 96 h after grafting. Results showed that pathological samples were surrounded by numerous allantoic vessels with a radially arranged 'spoke-wheel' pattern around the implant. The vascular counts in the CAMs treated with lipoma implants were comparable to that of FGF-2. The role played in vasoproliferative response by angiogenic cytokines (FGF-2, VEGF) released by adipocytes, by endogenous cytokines, such as FGF-2, stored in the CAM extracellular matrix and by angiogenic growth factors released by perivascular mononuclear cells around the newly-formed blood vessels, were supported by this study.
引用
收藏
页码:593 / 596
页数:4
相关论文
共 20 条
[1]  
BALL JM, 1928, SACK EM MEN ACCOUNT, P73
[2]   BASIC FIBROBLAST GROWTH-FACTOR EXPRESSION IN HUMAN OMENTAL MICROVASCULAR ENDOTHELIAL-CELLS AND THE EFFECT OF PHORBOL ESTER [J].
BIKFALVI, A ;
ALTERIO, J ;
INYANG, AL ;
DUPUY, E ;
LAURENT, M ;
HARTMANN, MP ;
VIGNY, L ;
RAULAIS, D ;
COURTOIS, Y ;
TOBELEM, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 144 (01) :151-158
[3]   T-LYMPHOCYTES SYNTHESIZE AND EXPORT HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR, MITOGENS FOR VASCULAR CELLS AND FIBROBLASTS - DIFFERENTIAL PRODUCTION AND RELEASE BY CD4+ AND CD8+ T-CELLS [J].
BLOTNICK, S ;
PEOPLES, GE ;
FREEMAN, MR ;
EBERLEIN, TJ ;
KLAGSBRUN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :2890-2894
[4]   Leptin, the product of Ob gene, promotes angiogenesis [J].
Bouloumié, A ;
Drexler, HCA ;
Lafontan, M ;
Busse, R .
CIRCULATION RESEARCH, 1998, 83 (10) :1059-1066
[5]  
BREM SS, 1978, CANCER, V41, P239, DOI 10.1002/1097-0142(197801)41:1<239::AID-CNCR2820410133>3.0.CO
[6]  
2-X
[7]   ANGIOGENIC ACTIVITY AS A MARKER OF NEOPLASTIC AND PRENEOPLASTIC LESIONS OF THE HUMAN BLADDER [J].
CHODAK, GW ;
HAUDENSCHILD, C ;
GITTES, RF ;
FOLKMAN, J .
ANNALS OF SURGERY, 1980, 192 (06) :762-771
[8]  
Elias H, 1983, GUIDE PRACTICAL STER, P25
[9]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61
[10]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763